Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News AmpliPhi Biosciences Corporation APHB

Healthcare Biotechnology
"Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:APHB)

Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

PR Newswire December 22, 2022

Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage

PR Newswire November 28, 2022

Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs

PR Newswire January 5, 2022

Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs

PR Newswire November 18, 2021

Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress

PR Newswire November 4, 2021

Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals

PR Newswire October 28, 2021

Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference

PR Newswire July 7, 2021

AmpliPhi Biosciences Announces Stockholder Approval of Business Combination with C3J Therapeutics

Business Wire May 8, 2019

AmpliPhi Biosciences Reports First Quarter 2019 Financial Results and Business Highlights

Business Wire May 6, 2019
View More News ››

Opinion & Analysis (NYSEAM:APHB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSEAM:APHB)

added more of this one

using dollar cost averaging as it goes up,so glta.
coolfooldumbguy - May 6, 2019

it's a big buy

for me this morning and should do well for me,so glta .
coolfooldumbguy - January 4, 2019

Old Russian phage research

Has anyone compared the long-standing russian use of phage v bacteria?  I wonder if some of the things being touted as IP were...
aee - June 2, 2016
View more Bullboard ››

Visionstate Corp.

Visionstate Corp.

Visionstate Corp.is a growth-oriented company that invests in the research and development of the Internet of Things, big ...
View More »